Mesoblast Limited
Mesoblast Limited (MSB) is a global leader in developing innovative cell-based therapies, primarily focusing on regenerative medicine. The company operates in the biotechnology sector and specializes in advanced therapeutic solutions for chronic conditions and diseases, including heart failure, spinal disc degeneration, and inflammatory diseases. Mesoblast's core products include allogeneic cell therapy products derived from adult stem cells, which aim to provide safer and more effective treatments compared to traditional therapies.